Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug

Clinical trials have begun for a drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by US biopharmaceutical company Nuvectis Pharma, Inc.

Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials

The safety, efficacy, and immunogenicity of a mRNA-based vaccine.

December 5, 2023

Medios acquires Dutch market leader in pharmaceutical compounding services – Biotech Investments

Medios AG / Key word(s): Mergers & Acquisitions/Expansion Medios acquires Dutch market leader in pharmaceutical compounding services 18-March-2024 / 20:41 CET/CEST Disclosure of an inside

March 19, 2024

Abbott, Medtronic partner on diabetes tech

Dive Brief: Abbott and Medtronic said Wednesday they will partner to create an integrated continuous glucose monitor that works with Medtronic’s diabetes technology. Abbott will

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.